The US Food and Drug Administration has approved the first drug to treat Covid-19, remdesivir, an antiviral medicine given through an IV for patients needing hospital admission
The drug, which California-based Gilead Sciences Inc is calling Veklury, cut the time to recovery by five days, from 15 days to 10 on average, in a large study led by the US National Institutes of Health.
It had been authorised for use on an emergency basis since spring, and now has become the first drug to win full US approval for treating Covid-19.
Gilead says Veklury is approved for people at least 12 years old and weighing at least 40 kilograms (88lb) who need hospital admission for their coronavirus infection.
It works by inhibiting a substance the virus uses to make copies of itself.
Comments: Our rules
We want our comments to be a lively and valuable part of our community - a place where readers can debate and engage with the most important local issues. The ability to comment on our stories is a privilege, not a right, however, and that privilege may be withdrawn if it is abused or misused.
Please report any comments that break our rules.
Read the rules here